{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:22:18Z","timestamp":1789510938911,"version":"build-2803163510"},"reference-count":45,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2022,7,17]]},"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1136\/flgastro-2022-102172","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T13:25:20Z","timestamp":1659619520000},"page":"162-166","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Can we be more proactive?"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8714-2367","authenticated-orcid":false,"given":"Dermot","family":"Gleeson","sequence":"first","affiliation":[{"name":"Liver Unit, Sheffield Teaching Hospitals Sheffield UK, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Walmsley","sequence":"additional","affiliation":[{"name":"PSC Support, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak J","family":"Trivedi","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Birmingham Biomedical Research Centre, Centre for Liver and Gastroenterology Research, University of Birmingham, Birmingham, United Kingdom, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9547-2809","authenticated-orcid":false,"given":"Deepak","family":"Joshi","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4568-0359","authenticated-orcid":false,"given":"Ben","family":"Rea","sequence":"additional","affiliation":[{"name":"Department of Clinical Radiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"2025090708500069000_14.2.162.1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90175-w","article-title":"Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies","volume":"11","author":"Aune","year":"2021","journal-title":"Sci Rep"},{"key":"2025090708500069000_14.2.162.2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234624","article-title":"The primary sclerosing cholangitis (PSC) wellbeing study: understanding psychological distress in those living with PSC and those who support them","volume":"15","author":"Ranieri","year":"2020","journal-title":"PLoS One"},{"key":"2025090708500069000_14.2.162.3","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1016\/S0618-8278(19)30812-6","article-title":"FRI-062-Identifying research priorities in primary sclerosing cholangitis: Driving clinically meaningful change from the patients\u2019 perspective","volume":"70","author":"Walmsley","year":"2019","journal-title":"J Hepatol"},{"key":"2025090708500069000_14.2.162.4","unstructured":"Walmsley M . Clinical need in PSC and clinically meaningful change: what is important to patients? 2016. Available: www.pscsupport.org.uk\/unmetneeds"},{"key":"2025090708500069000_14.2.162.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00288-4"},{"key":"2025090708500069000_14.2.162.6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26565"},{"key":"2025090708500069000_14.2.162.7","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"2025090708500069000_14.2.162.8","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/hep.30479","article-title":"Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system","volume":"69","author":"Goode","year":"2019","journal-title":"Hepatology"},{"key":"2025090708500069000_14.2.162.9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317993"},{"key":"2025090708500069000_14.2.162.10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23294"},{"key":"2025090708500069000_14.2.162.11","article-title":"EASL clinical practice guidelines on primary sclerosing cholangitis","volume":"51","year":"2022","journal-title":"J Hepatol. 2022 May 31. pii: S0168-8278(22)00326-9. doi: 10.1016\/j.jhep.2022.05.011"},{"key":"2025090708500069000_14.2.162.12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"2025090708500069000_14.2.162.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.08.013"},{"key":"2025090708500069000_14.2.162.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02575.x"},{"key":"2025090708500069000_14.2.162.15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"2025090708500069000_14.2.162.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00872.x"},{"key":"2025090708500069000_14.2.162.17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12016-019-08764-7","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC): a comprehensive review","volume":"58","author":"Song","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025090708500069000_14.2.162.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04067.x"},{"key":"2025090708500069000_14.2.162.19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejso.2018.09.008","article-title":"Clinical outcome after resection of early-stage hilar cholangiocarcinoma","volume":"45","author":"Stremitzer","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"2025090708500069000_14.2.162.20","doi-asserted-by":"crossref","unstructured":"Fatourou E , Hyde S , et al, UK PSC . National audit of management of diagnosis, surveillance and management of primary sclerosing cholangitis in the United Kingdom. Gut 2021.doi:10.1136\/gutjnl-2021-BSG.16","DOI":"10.1136\/gutjnl-2021-BSG.16"},{"key":"2025090708500069000_14.2.162.21","doi-asserted-by":"crossref","unstructured":"Gleeson D , Haq I , Harrison LC . Audit of investigations performed for cholangiocarcinoma surveillance in patients with primary sclerosing cholangitis. Gut. Abstract in press, doi not yet available 2022.","DOI":"10.1136\/gutjnl-2022-BSG.131"},{"key":"2025090708500069000_14.2.162.22","first-page":"765A","article-title":"The challenging road of PSC caretaking \u2013 a survey uncovering different strategies throughout Europe","volume":"72","author":"Ytting","year":"2020","journal-title":"Hepatology"},{"key":"2025090708500069000_14.2.162.23","article-title":"Hepatobiliary malignancy surveillance strategies in primary sclerosing cholangitis associate with reduced mortality","volume":"75","author":"Bergquist","year":"2021","journal-title":"J Hepatol"},{"key":"2025090708500069000_14.2.162.24","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.29293","article-title":"Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group","volume":"66","author":"Schramm","year":"2017","journal-title":"Hepatology"},{"key":"2025090708500069000_14.2.162.25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/liv.13548","article-title":"Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977-2011","volume":"38","author":"S\u00f8rensen","year":"2018","journal-title":"Liver Int"},{"key":"2025090708500069000_14.2.162.26","first-page":"91A","article-title":"Population-bBased prospective surveillance of patients with primary sclerosing cholangitis (PSC) for early detection of cholangiocarcinoma","volume":"74","author":"Villard","year":"2021","journal-title":"Hepatology"},{"key":"2025090708500069000_14.2.162.27","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1097\/MIB.0000000000000181","article-title":"Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation","volume":"20","author":"Negr\u00f3n","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2025090708500069000_14.2.162.28","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali","year":"2018","journal-title":"Hepatology"},{"key":"2025090708500069000_14.2.162.29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/apt.15146","article-title":"Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis","volume":"49","author":"Wannhoff","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090708500069000_14.2.162.30","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/hep.31575","article-title":"Early cholangiocarcinoma detection with magnetic resonance imaging versus ultrasound in primary sclerosing cholangitis","volume":"73","author":"Eaton","year":"2021","journal-title":"Hepatology"},{"key":"2025090708500069000_14.2.162.31","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30158-8"},{"key":"2025090708500069000_14.2.162.32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22441"},{"key":"2025090708500069000_14.2.162.33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaoncol.2016.3147","article-title":"MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma","volume":"3","author":"Kim","year":"2017","journal-title":"JAMA Oncol"},{"key":"2025090708500069000_14.2.162.34","unstructured":"Radiologists RCo . Clinical radiology UK workforce census 2021 report, 2022. Available: https:\/\/wwwrcracuk\/clinical-radiology\/rcr-clinical-radiology-census-report-2021"},{"key":"2025090708500069000_14.2.162.35","unstructured":"Radiologists RCo . Clinical radiology UK workforce census 2020 report, 2021. Available: https:\/\/wwwrcracuk\/publication\/clinical-radiology-uk-workforce-census-2020-report"},{"key":"2025090708500069000_14.2.162.36","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316801"},{"key":"2025090708500069000_14.2.162.37","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317817"},{"key":"2025090708500069000_14.2.162.38","doi-asserted-by":"crossref","first-page":"100143","DOI":"10.1016\/j.jhepr.2020.100143","article-title":"Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers","volume":"2","author":"Vedeld","year":"2020","journal-title":"JHEP Rep"},{"key":"2025090708500069000_14.2.162.39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24581"},{"key":"2025090708500069000_14.2.162.40","unstructured":"Radiologists RCo . Standards of practice for computed tomography colonography (CTC) joint guidance from the British Society of gastrointestinal and abdominal radiology and the Royal College of radiologists Position statement; 2021."},{"key":"2025090708500069000_14.2.162.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.08.005"},{"key":"2025090708500069000_14.2.162.42","doi-asserted-by":"publisher","DOI":"10.1177\/2050640615581577"},{"key":"2025090708500069000_14.2.162.43","unstructured":"B A . Effect of simvastatin on the prognosis of primary primary sclerosing cholangitis (PSC) (PiSCATIN). Available: https:\/\/clinicaltrialsgov\/ct2\/show\/NCT04133792"},{"key":"2025090708500069000_14.2.162.44","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"American College of G. ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2025090708500069000_14.2.162.45","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","article-title":"AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: expert review","volume":"17","author":"Bowlus","year":"2019","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2022-102172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:50:12Z","timestamp":1757260212000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2022-102172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,8]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/flgastro-2022-102172"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2022-102172","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]}}}